semaglutide fact sheet GLP1 Printable Patient Education: Weight Loss Flyer, Editable Canva Template (digital Download) Novo Nordisk receives FDA approval

In the low/no CKD risk cohort, 31 (10.5%) patients reported moderate (n = 24) or severe (n = 7) GI AEs in the first 6 months of treatment

Beyond the First Month For many, gradual changes continue to unfold over several months

Most Common Uses Semaglutide is primarily prescribed as a once-weekly subcutaneous injection to manage type 2 diabetes in adults

If you can only eat a small amount, make sure the majority of those calories come from protein

PAD: Conceptualization, Validation, Methodology, Software, Project Administration, Writing Review and Editing

Immediate lab / workup items I would suggest discussing these next steps: Repeat and confirm Fasting lipid panel ApoB HbA1c Fasting glucose Look for To view or add a comment, sign in 836 followers